- Home
- / Fresenius
Fresenius
Stock Price
€40.9
2023-05-25
Market Capitalization
€12.6 B
2023-05-03
Revenue
€19.4 B
FY, 2022
Fresenius Summary
Company summary
- Overview
- Fresenius is a global healthcare group offering products and services for dialysis, hospitals, and outpatient treatment. It focuses on clinic operations as well as on engineering and services for hospitals and other health care facilities.
- Type
- Public
- Status
- Active
- Founded
- 1912
- HQ
- Bad Homburg vor der Höhe, DE | view all locations
- Website
- https://www.fresenius.com/
- Cybersecurity rating
- ESG rating
Key people
Ernst Wastler, CEO Fresenius Vamed
Operating MetricsView all
Dialysis Centers
3.6K
6.0%
FY, 2016
Patients
308.5K
4.8%
FY, 2016
Treatments
46.5M
4.6%
FY, 2016
LocationsView all
11 locations detected
Bad Homburg vor der Höhe, HE HQ
Germany
Else-Kröner-Straße 1
Lake Zurich, IL
United States
3 Corporate Dr
Waltham, MA
United States
920 Winter St
Milsons Point, NSW
Australia
l17/61 Lavender St
Rio de Janeiro, RJ
Brazil
Américas Corporate - Av. das Américas, 3443 - Barra da Tijuca
São Paulo, SP
Brazil
Av. Marginal Projetada, 1652 - g1 - Tamboré
Fresenius Financials
Summary financials
- Revenue (Q1, 2023)
- €4.7B
- Gross profit (Q1, 2023)
- €1.6B
- Net income (Q1, 2023)
- €133.9M
- Cash (Q1, 2023)
- €1.2B
- EBIT (Q1, 2023)
- €273.2M
- Enterprise value
- $24.6B